Laboratorios Farmaceuticos Rovi, S.A. (FRA:41L)

FRA:41L Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,041	3,220	3,213	1,925	4,138	2,099
Market Cap Growth	-3.88%	0.22%	66.93%	-53.49%	97.10%	55.36%
Enterprise Value	3,126	3,340	3,223	1,902	4,066	2,139
Last Close Price	58.40	60.96	59.05	34.58	68.07	35.21
PE Ratio	25.10	23.52	18.86	9.64	27.03	34.38
PS Ratio	4.20	4.22	3.87	2.35	6.38	5.00
PB Ratio	4.81	5.54	5.91	3.69	8.79	5.62
P/TBV Ratio	5.19	5.92	6.28	3.92	9.42	6.18
P/FCF Ratio	27.39	40.68	54.04	10.30	37.89	278.47
P/OCF Ratio	17.42	23.29	28.37	8.10	27.69	44.79
EV/Sales Ratio	4.32	4.37	3.89	2.33	6.27	5.09
EV/EBITDA Ratio	17.46	16.73	13.54	7.01	20.69	23.87
EV/EBIT Ratio	20.77	18.69	14.69	7.50	22.57	28.55
EV/FCF Ratio	28.16	42.20	54.22	10.18	37.23	283.73
Debt / Equity Ratio	0.20	0.20	0.12	0.14	0.16	0.20
Debt / EBITDA Ratio	0.69	0.56	0.27	0.26	0.36	0.80
Debt / FCF Ratio	1.11	1.45	1.10	0.39	0.67	9.87
Asset Turnover	0.81	0.94	0.99	1.01	0.99	0.77
Inventory Turnover	0.82	0.89	1.07	1.10	1.14	0.95
Quick Ratio	1.30	0.99	0.83	1.04	1.35	1.10
Current Ratio	3.02	3.13	2.55	2.12	2.66	2.97
Return on Equity (ROE)	20.34%	24.33%	31.99%	40.24%	36.24%	17.54%
Return on Assets (ROA)	10.46%	13.69%	16.34%	19.68%	17.23%	8.63%
Return on Capital (ROIC)	13.05%	17.12%	22.81%	27.88%	22.69%	10.95%
Return on Capital Employed (ROCE)	20.40%	26.50%	36.60%	43.40%	33.20%	16.60%
Earnings Yield	3.98%	4.25%	5.30%	10.37%	3.70%	2.91%
FCF Yield	3.65%	2.46%	1.85%	9.71%	2.64%	0.36%
Dividend Yield	1.30%	1.53%	1.87%	3.74%	1.40%	1.08%
Payout Ratio	39.48%	41.24%	40.54%	25.55%	13.80%	15.89%
Buyback Yield / Dilution	-	3.73%	0.51%	3.50%	-0.03%	-0.37%
Total Shareholder Return	1.30%	5.26%	2.38%	7.24%	1.37%	0.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.